A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies
Clinical trial NCT07294300 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07294300
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2028-02-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.